Page 135 - 《中国药房》2026年9期
P. 135

·综述·


          基于AMPK信号通路探讨中药干预肌少症的研究进展
                                                                                             Δ

                 1*
                                            1
                           2
                                                                       3 #
                                   2
          范文玉 ,黄柏融 ,洪聪敏 ,陈 言 ,王佳音 ,高 静 ,冯晓东 (1. 河南中医药大学康复医学院,郑州
                                                              3
                                                     1
          450046;2.广州中医药大学针灸康复临床医学院,广州 510006;3.河南中医药大学第一附属医院康复诊疗中
          心,郑州 450099)
          中图分类号  R285      文献标志码  A      文章编号  1001-0408(2026)09-1229-07
          DOI  10.6039/j.issn.1001-0408.2026.09.21
          摘  要  肌少症是一种以骨骼肌质量减少与功能进行性下降为特征的系统性骨骼肌疾病,其发生发展涉及多条信号通路。其中,
          AMP活化的蛋白质激酶(AMPK)信号通路作为调控细胞能量稳态的关键通路,能够改善糖脂代谢异常、平衡骨骼肌蛋白的合成
          与降解、改善线粒体功能、促进细胞自噬、抑制炎症反应与氧化应激,在骨骼肌代谢调节与功能维持中发挥重要作用。本文主要综
          述多酚类、黄酮类、萜类等多种中药单体,中药枸杞、阿胶、西洋参等的提取物以及归芪壮筋汤、健脾强肌颗粒、芪骨胶囊等中药复
          方通过调控AMPK信号通路促进肌蛋白合成、抑制蛋白降解、改善线粒体功能及减轻炎症与氧化应激,从而干预肌少症的研究进
          展,并探讨其分子机制,旨在深入阐释中药防治肌少症的作用基础,为相关创新药物的开发提供理论支撑。
          关键词  肌少症;AMPK;中药单体;中药提取物;中药复方

          Research progress on the intervention of sarcopenia with traditional Chinese medicine based on the AMPK
          signaling pathway
                                                                                 1
                                                                                            3
                                                                   1
                                                       2
          FAN Wenyu ,HUANG Bairong ,HONG Congmin ,CHEN Yan ,WANG Jiayin ,GAO Jing ,FENG Xiaodong             3
                     1
                                      2
         (1. School  of  Rehabilitation  Sciences,  Henan  University  of  Chinese  Medicine,  Zhengzhou  450046,China;
          2.Clinical  Medical  College  of  Acupuncture  Moxibustion  and  Rehabilitation,  Guangzhou  University  of  Chinese
          Medicine,  Guangzhou  510006,China;3. Rehabilitation  Diagnosis  and  Treatment  Center,  the  First  Affiliated
          Hospital, Henan University of Traditional Chinese Medicine, Zhengzhou 450099, China)
          ABSTRACT   Sarcopenia  is  a  systemic  skeletal  muscle  disorder  characterized  by  a  decrease  in  skeletal  muscle  mass  and
          progressive  decline  in  function,  with  multiple  signaling  pathways  involved  in  its  occurrence  and  development.  Among  them,  the
          AMP-activated  protein  kinase (AMPK)  signaling  pathway,  as  a  key  pathway  regulating  cellular  energy  homeostasis,  plays  an
          important  role  in  the  regulation  of  skeletal  muscle  metabolism  and  functional  maintenance  by  improving  abnormalities  in  glucose
          and  lipid  metabolism,  balancing  skeletal  muscle  protein  synthesis  and  degradation,  improving  mitochondrial  function,  promoting
          autophagy,  and  inhibiting  inflammatory  responses  and  oxidative  stress.  This  article  reviews  the  research  progress  on  how  various
          traditional  Chinese  medicine (TCM)  monomers,  including  polyphenols,  flavonoids,  and  terpenoids;  various  traditional  Chinese
          medicine extracts, such as those from Lycium barbarum, Asini Corii Colla, and Panax quinquefolium, and TCM compounds, such
          as  Guiqi  zhuangjin  decoction,  Jianpi  qiangji  granules,  and  Qigu  capsules,  intervene  in  sarcopenia  by  regulating  the  AMPK
          signaling  pathway  to  promote  muscle  protein  synthesis,  inhibit  protein  degradation,  improve  mitochondrial  function,  and  alleviate
          inflammation  and  oxidative  stress. Additionally,  their  molecular  mechanisms  are  explored. The  aim  is  to  deeply  elucidate  the  basis
          of TCM  in  the  prevention  and  treatment  of  sarcopenia  and  to  provide  theoretical  support  for  the  development  of  related  innovative
          drugs.
          KEYWORDS    sarcopenia;  AMPK;  traditional  Chinese  medicine  monomer;  traditional  Chinese  medicine  extract;  traditional
          Chinese medicine compound



                                                                 肌少症是一种与年龄相关的综合征,以全身性骨骼
             Δ 基金项目 国 家 重 点 研 发 计 划“ 中 医 药 现 代 化 ”课 题(No.    肌质量及躯体功能减少/减退为核心特征,与跌倒、骨折、
          2023YFC3503705)                                    失能及死亡风险升高密切相关 。随着全球人口老龄化
                                                                                       [1]
             *第一作者 硕士研究生。研究方向:常见功能障碍中医康复的临
                                                             进程的持续加速,肌少症已成为亟待关注的重大公共卫
          床与基础研究。E-mail:fwy15516174220@163.com
             # 通信作者 主任医师,博士生导师,博士。研究方向:常见功能障                 生问题。据估计,肌少症在全球普通人群中的患病率为
          碍中医康复的临床与基础研究。E-mail:fxd0502@163.com               5%~10%,在老年人群中为 10%~40%,而在合并代谢


          中国药房  2026年第37卷第9期                                                China Pharmacy  2026 Vol. 37  No. 9    · 1229 ·
   130   131   132   133   134   135   136   137   138   139   140